drugset / Trial / NCT04441255

A Study to Evaluate the Effect of High-Fat Meal on TAK-788 Pharmacokinetics (PK) in Healthy Adult Participants

NCT04441255

Phase 1 Completed 14 enrolled Takeda
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to characterize the effect of a high-fat meal on the PK of TAK-788 administered in healthy participants.

Timeline

Start
2020-07-01
Primary completion
2020-08-10
Completion
2020-08-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Mobocertinib Small molecule 160 mg Oral

Indications

No indication recorded.